Insulet Corporation 019 Manuale Utente

Pagina di 190
Introduction
x
OneTouch® Verio™ test strips are used with the built-in One-
Touch® Verio™ meter for the quantitative measurement of blood 
glucose in fresh whole capillary blood from the finger, upper arm 
and palm. OneTouch® Verio™ Control Solutions are used to verify 
that the meter and test strips are working together properly and 
that the test is performed correctly.
Contraindications
Insulin pump therapy is NOT recommended for people who are 
either:
Unable to perform at least four (4) blood glucose tests per day
Unable to maintain contact with their healthcare provider
Unable to use the System according to instructions
Do not use the integrated OneTouch® Verio™ Blood Glucose 
Monitoring System for:
Testing on newborns
Testing arterial blood
Diagnosing of or screening for diabetes mellitus
 
The mylife OmniPod System is designed to use 
rapid-acting U-100 insulin. The following U-100 
rapid-acting insulin analogs have been tested and 
found to be safe for use in the Pod: NovoRapid®, 
Humalog®, or Apidra®. NovoRapid® is compatible 
with the mylife OmniPod System for use up to 72 
hours (3 days). Before using different insulins with 
the mylife OmniPod System, check the insulin drug 
label to make sure it can be used with a pump. Refer 
to the insulin labeling and follow your healthcare 
provider’s directions for how often to replace the Pod.
Not recommended for individuals with hearing 
loss. Always verify ability to hear Pod/PDM alerts 
and alarms.
The Pod and PDM may be affected by strong radi-
ation or magnetic fields. Before having an X-ray, MRI, 
or CT scan (or any similar test or procedure), remove 
your Pod and put it and the PDM outside the treat-
ment area. Check with your healthcare provider for 
Pod removal guidelines.